Difficulty: Medium
Average Score: 79%
Practice
Which of the curves best depicts the log dose-response curve of that agonist when a fixed dose of a competitive α antagonist is given concomitantly?
Correct answer
B
Rationale
In pharmacology, understanding dose-response curves is crucial for predicting drug effects. When a fixed dose of a competitive ╬▒ antagonist is given concomitantly with an agonist, it will shift the dose-response curve to the right due to competitive inhibition.
Option B is the correct choice because it represents a rightward shift in the dose-response curve, indicating competitive antagonism. This shift means higher doses of the agonist are needed to produce the same effect in the presence of the antagonist.
Options A, C, and D can be eliminated because they do not show the characteristic rightward shift seen with competitive antagonists. Curve P (A) may indicate a non-competitive antagonist, while Curves R (C) and S (D) do not demonstrate any form of antagonism.
Educationally, this question reinforces the concept of competitive antagonism and how it influences dose-response relationships. Understanding these principles is essential for predicting drug interactions and designing effective treatment regimens in clinical practice.
Option B is the correct choice because it represents a rightward shift in the dose-response curve, indicating competitive antagonism. This shift means higher doses of the agonist are needed to produce the same effect in the presence of the antagonist.
Options A, C, and D can be eliminated because they do not show the characteristic rightward shift seen with competitive antagonists. Curve P (A) may indicate a non-competitive antagonist, while Curves R (C) and S (D) do not demonstrate any form of antagonism.
Educationally, this question reinforces the concept of competitive antagonism and how it influences dose-response relationships. Understanding these principles is essential for predicting drug interactions and designing effective treatment regimens in clinical practice.